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Abstract  
Cell activation is a vital step for T cell memory/effector differentiation as well as for productive 
HIV infection. To identify novel regulators of this process, we used next generation sequencing 
to profile changes in microRNA expression occurring in purified human naive CD4 T cells in 
response to TCR stimulation and/or HIV infection. Our results demonstrate, for the first time, the 
transcriptional up-regulation of miR-34c-5p in response to TCR stimulation in naive CD4 T cells. 
The induction of this miR was further consistently found to be reduced by both HIV-1 and HIV-2 
infections. Over-expression of miR-34c-5p led to changes in the expression of several genes 
involved in TCR signaling and cell activation, confirming its role as a novel regulator of naive 
CD4 T cell activation. We additionally show that miR-34c-5p promotes HIV-1 replication, 
suggesting that its down-regulation during HIV infection may be part of an anti-viral host 
response.  
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Introduction  
CD4 T-helper cells are the central orchestrators of immune responses. Priming of naive CD4 T 
cells via their specific T cell receptor (TCR) induces distinctive gene expression programs 
leading to cell activation, proliferation and ultimately differentiation into specialized subsets of 
effector and regulatory cells (Yamane & Paul, 2013). This complex chain of events has been 
shown to be tightly regulated by microRNAs (miRs) (Pagani et al, 2013). miRs function as post-
transcriptional regulators that can serve as fine-tuning modulators, buffers, on-off or delay 
switches that coordinate the expression of up to several hundreds of genes in a short-time (Flynt 
& Lai, 2008). miRs are 22-23nt small non-coding RNAs, generated from larger precursor 
transcripts by the enzymes Drosha and Dicer, that negatively regulate gene expression by direct 
base-pairing interactions with target mRNA molecules as part of the RISC miR-protein complex 
(Bartel, 2004). These miR-dependent interactions inhibit translation, and may result in the 
degradation of the targeted mRNA. Early studies of miR function identified the Dicer pathway as 
a critical regulator of T cell differentiation (Cobb et al, 2005; Muljo et al, 2005). Subsequently, 
several miRs have been reported to be critical for immune system function (reviewed by 
(Kroesen et al, 2015)). Among the immunologically relevant miRs, miR-155-5p is a particularly 
important example, being induced early following receptor-mediated activation in both B and T 
cells (Rodriguez et al, 2007; Thai et al, 2007), and linked to effector/suppressor T cell 
differentiation (Banerjee et al, 2010; Lu et al, 2015). Hence, in line with studies in many other 
biological systems, miRs have emerged as critical regulators of T cell activation and function.  
Previous studies addressing the role of miRs in T cell activation have mainly utilized T cell lines 
(Rossi et al, 2011). Moreover, the few studies using human primary cells focused on bulk CD4 T 
cells, which include multiple T-helper cell subsets with distinct properties (Farber et al, 2013). 
There are very limited data on naive CD4 T cells (Pagani et al, 2013), a relatively homogeneous 
population considered fundamental in ensuring life-long immune competence. Naive CD4 T cells 
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have a diverse TCR repertoire, allowing responsiveness to novel pathogens, and broad potential 
for differentiation into distinct effector CD4 T-helper subsets (Surh & Sprent, 2008).  
CD4 T cells are the main targets of human immunodeficiency virus (HIV) infection, which 
depends on cell activation for efficient viral replication and sustained production of new 
infectious virus particles (Stevenson et al, 1990; Rice & Kimata, 2015). Quiescent naive CD4 T 
cells can be infected by HIV-1 (Chavez et al, 2015). Nevertheless, they feature a limited ability to 
support viral production (Chavez et al, 2015). This was proposed to be mainly due to the activity 
of SAMHD1, a host restriction factor that is down-regulated upon TCR stimulation (Baldauf et al, 
2012). Interestingly, SAMHD1 is counteracted by Vpx, a viral protein that is encoded by HIV-2 
and some SIV strains, but not by HIV-1 (Baldauf et al, 2012; Chauveau et al, 2015). The 
regulatory interplay between HIV and host miRs and its possible influence on replication 
efficiency is a matter of active debate (reviewed by Barichievy et al, 2015).  
To further investigate the connection between miRs, T cell activation and HIV replication in a 
biologically relevant context we decided to focus on human naive CD4 T cells and generate an 
in-depth view of their miR expression profile and of the changes it undergoes in response to 
TCR stimulation and/or HIV infection.  For this purpose, we purified naive CD4 T cells from the 
blood of seronegative individuals, stimulated them via TCR, infected both non-stimulated and 
TCR-stimulated cells with either HIV-1 or HIV-2, and produced small RNA libraries for expression 
profiling by Next Generation Sequencing (NGS). Our results identify miR-34c-5p as a common 
link between both processes, impacting on several pathways critical for cell activation and HIV 
replication.  
 
Results 
MicroRNA profile of human naive CD4 T cells and the impact of HIV infection  
The miRNA profile of human naive CD4 T cells has yet to be fully characterized (Pagani et al, 
2013). We used NGS at high sequencing depth to generate an unbiased microRNA expression 
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profile from small RNAs isolated from purified human naive CD4 T cells of healthy blood donors. 
Due to the low amount of RNA obtained from each individual, total RNA from three donors was 
pooled prior to library generation. Two independent sequencing libraries of naive CD4 T cells 
were produced with >6x106 reads. 
A total of 519 distinct mature miRs were detected across both libraries (Fig 1A), the majority of 
which (~69%) were expressed at very low levels (<100 reads), although more than 105 reads 
were detected for each of the eight most highly expressed miRs. The most abundant miRs in 
human naive CD4 T cells were miR-146b-5p, miR-21-5p, miR-let-7a-5p and miR-101-3p (Fig 
1A).  
The remaining 20% of reads that did not map to known miRs were annotated as 'other non-
coding small RNAs', 'protein coding features' or ‘unknown transcripts'. Reads classified as 
unknown transcripts and displaying 22-23 nt in size were investigated as possible novel 
miRNAs. Results revealed the presence of several novel miRNA gene candidates, all of which 
were expressed at very low levels (<0.01% of the total miR reads), precluding their experimental 
validation (Table EV1).  
It has been increasingly reported that HIV infection impacts on quiescent cells despite their 
inability to support productive viral replication (Doitsh et al, 2010; Chavez et al, 2015; Zerbato et 
al, 2016). Moreover, the HIV-2 acessory protein Vpx has been shown to counteract the role of 
the host restriction factor SAMHD1 (Chauveau et al, 2015), which limits HIV-1 replication in 
naive CD4 T cells (Baldauf et al, 2012). However, so far the impact of HIV-1 on miR expression 
has only been assessed in the context of infected cell lines or activated T cells. We therefore 
asked whether HIV-1 or HIV-2 infection alters the miR profile of human naive CD4 T cells. For 
this purpose, we performed a parallel infection of naive CD4 T cells from the same set of donors 
for 24h with either HIV-1NL4-3 or HIV-2ROD molecular clones, using a comparable number of viral 
copies of both viruses. RNA samples isolated from these cells were pooled as before to 
generate two small RNA-seq libraries for each condition (control, HIV-1 infected and HIV-2 
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infected).  
Comparison of the NGS profile between control and infected libraries revealed a similar miR 
expression levels irrespective of HIV infection. As shown in Fig 1B and 1C, we did not detect a 
significant effect of either HIV-1 or HIV-2 infection on the miR profile of unstimulated naive CD4 T 
cells. This occurred in spite of evidence of viral entry and subsequent retrotranscription (Fig 
EV1A). Additionally, we observed that the major determinant for sample clustering was the donor 
pool rather than the infection status (Fig EV1B). This implies that HIV had no major effect and 
genetic distances were solely imposed by the individual’s genetic backgrounds.  
Overall, our data support a lack of impact of both HIV-1 and HIV-2 infection on the miR 
expression profile of quiescent naive CD4 T cells. 
 
Modulation of human naive CD4 T cell miR profile upon TCR stimulation 
To address how the naive CD4 T cell microRNome is altered in response to TCR stimulation, we 
stimulated purified naive CD4 T cells from healthy individuals in vitro for 72h with immobilized 
anti-CD3 and soluble anti-CD28 monoclonal antibodies (mAb). Total RNA from these samples 
was pooled to generate two sets of paired small RNA-seq libraries of unstimulated and 
stimulated naive cells.   
Analysis of these datasets revealed that the average expression level of approximately half of 
the miRs displayed slight changes in response to TCR stimulation (log2 fold change >1 or <-1), 
of which ~60% were down-regulated (Fig 2A and Fig EV2A). However, significant changes in 
expression were only observed for miR-155-5p and miR-34c-5p, with a 5.4 and 8.2 log2 fold 
increase in miR abundance, respectively (Fig 2A).  
Although miR-155-5p has been consistently reported to be upregulated in response to activation 
in both B and T cells (Haasch et al, 2002; Kluiver et al, 2005), miR-34c-5p has not been 
previously described as being involved in this process. The differential expression of these miRs 
by RT-qPCR was validated in individual RNA samples to exclude the possibility of an analysis 
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bias in our NGS study due to the pooling of RNA samples from different individuals. As shown in 
Fig 2B, results were found to be in good agreement with the NGS quantification for both miR-
155-5p and miR-34c-5p. miR-34c-5p expression was below the RT-qPCR detection limit (Fig 
EV2B) in unstimulated naive CD4 T cells, and became clearly detectable in stimulated cells in all 
individuals tested (Fig 2B and Fig EV2C), supporting the conclusion that it is strongly induced in 
response to TCR stimulation.  
We next performed a time-course study to investigate the dynamics of the observed miR-34c-5p 
induction. Naive CD4 T cells from healthy donors were kept in culture for an additional 72h after 
removal of the TCR-stimulus, and we monitored proliferation and cell activation by flow 
cytometry using the markers Ki67 and CD71, respectively, and quantified miR-34c-5p 
expression levels at 24h intervals. As before, the miR-34c-5p expression level was below the 
quantification limit in naive cells and displayed a significant increase that extended well beyond 
the 72h timepoint, starting to decline around the same time cell proliferation stabilized (Fig 2C). 
This response occured at a later timepoint than the one observed for miR-155-5p (see Fig 
EV2D) and was barely seen in the case of one donor, whose naive CD4 T cells displayed 
minimal proliferation and activation after TCR stimulation (Fig 2C). This result confirmed the 
dependence of miR-34c-5p induction on the ability of naive cells to efficiently respond to TCR 
signaling.  
To investigate whether the accumulation of mature miR-34c-5p resulted from increased 
transcription, we evaluated the expression of both the miR and its primary transcript by semi-
quantitative RT-PCR in an independent time-course study with different individuals. The primary 
transcript was undetectable in unstimulated naive CD4 T cells, but increased upon TCR-
mediated stimulation with similar kinetics to the mature miR-34c-5p (Fig EV2E).   
We conclude that miR-34c-5p transcription is induced by TCR-mediated signaling, resulting in 
an increase of mature miR expression levels, which then decline as cell proliferation plateaus. 
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These results identify miR-34c-5p as a novel player in the naive CD4 T cell activation pathway. 
  
Activation induced miR-34c-5p expression is down-regulated upon HIV infection  
In order to identify miRs that connect the process of T cell activation and HIV infection we 
generated additional small RNA-seq libraries to investigate the miR expression profile after HIV-
1 or HIV-2 infection of in vitro stimulated naive CD4 T cells. For this purpose, cells isolated from 
healthy donors were subjected to a 72h TCR stimulation as described above, followed by 
infection with HIV-1NL4-3 or HIV-2ROD molecular clones for 24h. Samples from 3 individuals were 
pooled as before for small RNA-seq profiling. The infection status of the different cell samples 
was validated before pooling by quantification of cell-associated proviral DNA and gag mRNA 
levels (Fig EV1C).  
Comparison of uninfected and HIV infected small RNA-seq libraries revealed that most of the 
changes in miR expression were less than two fold (Fig 3A and 3B). Of note, 6 miRs (miR-34c-
5p, miR-126-3p, miR-126-5p, miR-143-3p, miR-379-5p and miR-1268a) were found to be 
differentially expressed in response to HIV-1 infection (Table 1). miR-34c-5p was the only miR 
that displayed a consistent behavior in response to both HIV-1 and HIV-2 infection (-1.8 fold and 
-2.44 fold change, respectively; Fig 3A and 3B). RT-qPCR quantification of its expression in 
samples from individual donors confirmed that this effect was significant in response to both 
viruses (Fig 3C). Interestingly, the effect of either HIV-1 or HIV-2 infection on miR-34c-5p 
expression was the opposite of that seen for TCR stimulation. 
Overall, our data suggests that miR-34c-5p may represent an important link between the cellular 
pathways involved in T cell activation and HIV infection, therefore warranting further 
investigation. 
 
miR-34c-5p expression promotes HIV-1 replication 
Next we asked whether miR-34c-5p impacts on HIV replication. For this purpose, we generated 
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a model for miR overexpression using Jurkat T cells, in view of the low transfection efficiency in 
primary T cells. We chose this T cell line because it lacks miR-34c-5p expression (Fig EV3A). 
Cells were transfected with a pcDNA3 vector containing the pre-miR-34c-5p precursor sequence 
and selected for antibiotic resistance, allowing us to isolate both pools and clones of stably 
transfected cells (J34c cells), in parallel with control cells transfected with the empty parental 
vector (JØ cells). Both pools of stably transfected cells and the derived clonal lines expressed 
high levels of the miR-34c-5p (Fig EV3A). Although by qPCR quantification we were unable to 
detect miR-34c-5p expression in JØ cells, considering the established detection limit (see Fig 
EV2B), we estimate that the levels of this miR in J34c correspond to a minimum increase of 700 
fold. Of note, miR-34c-5p is expressed at higher levels than miR-21, one of the most abundant 
miRs in T cells (see Fig EV3A and Fig 1A, Fig2A and Fig EV2A for miR-21 abundance in T cells). 
JØ and J34c cells were infected with HIV-1NL4-3 and the efficiency of viral infection and replication 
was assessed by measuring the levels of cell associated viral DNA, mRNA and protein, as well 
as virus production, at 24 and 48 hours. Although no significant increase in total proviral DNA 
was seen at either time point in J34c cells compared to JØ cells (Fig 4A, left), Tat mRNA levels 
increased in J34c cells at both time points, reaching significance at 48 hours post-infection (Fig 
4A, center). Moreover, the levels of virus particle production were also increased in the J34c 
infections at 48 hours, as determined by RT activity in culture supernatant (Fig 4A, right).  In 
agreement, intracellular levels of HIV-1 Gag protein expression at 48 hours measured by flow 
cytometry were found to be increased in infected J34c cells (Fig 4B). 
In order to validate that this effect was a direct consequence of miR-34c-5p overexpression, we 
performed additional infections of J34c cells treated with cholesterol-conjugated antagomiR 
against either the miR or control. Using a previously described protocol for miR knockdown in 
lymphocytes (Haftmann et al, 2015), we were able to obtain an efficient down-regulation of miR-
34c-5p after 24h treatment that remained stable up to 96h, as evaluated by qRT-PCR (Fig EV3B 
and Fig 4C). Therefore, J34c cells were infected with HIV-1NL4-3 after 24h antagomiR treatment in 
EMBOJ-2016-94335_Revised manuscript_Page 11 of 40 
 
 
three independent experiments and viral parameters quantified after 48h. The miR knockdown 
was associated with a decrease in the viral abundance in culture supernatants quantified by RT 
activity, confirming that miR-34c-5p has a facilitator role in viral production (Fig 4C). In 
agreement, a decrease in Tat mRNA was also observed (Fig 4C). On the other hand, proviral 
DNA levels increased after miR knockdown, which supports a negative modulation of pre-
integration processes by miR-34c-5p, possibly contributing to reduce the establishment of viral 
reservoirs (Fig 4C). 
Altogether, these results suggest that miR-34c-5p influences multiple pathways in the HIV cell 
cycle with a positive net result on HIV-1 replication through a predominant effect on post-
integration events. 
  
miR-34c-5p regulates genes involved in CD4 T cell signaling and function  
To further investigate the pathways modulated by miR-34c-5p, the transcriptome of three J34c 
clones was profiled and compared with three control JØ clones using the Affymetrix Human 
Gene ST array v2.0 (Fig EV4). Differential expression (DE) analysis identified 82 protein-coding 
genes with significant variation, with 78% of the 40 down-regulated genes predicted to be 
potential miR-34c-5p targets (Fig 5A and Table EV2).  We selected 10% of the DE genes, 
encompassing the range of fold changes and including both predicted miR-34c-5p targets and 
non-target genes, for independent RT-qPCR quantification. mRNA levels of all of these genes 
varied in J34c cells relative to control in agreement with the microarray data, thus confirming the 
robustness of the DE analysis (Fig 5B).  
Gene set enrichment analysis including all the DE genes identified 104 GO terms as being 
significantly enriched (Table EV3), with a large number of these being related to signaling or 
immune system functions (14% and 10%, respectively), including the TCR signaling pathway 
(Fig 6A).  Additionally, the GeneMania database was used to identify known gene and protein-
protein interactions involving the DE genes and perform a gene set enrichment analysis on the 
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resulting gene interaction network (Fig 6B). 79 out of the 82 DE genes were found to be 
connected in a single interaction network, whose significant biological functions were strongly 
related to T cell signaling and activation (Table EV4). Interestingly, the results of these functional 
enrichment analyses were similar when using either all DE genes or just those that were up-
regulated. In contrast, the down-regulated gene subset, which is expected to encompass miR-
34c-5p mRNA targets, did not have any clear functional associations. Therefore, the observed 
changes in the T cell transcriptome linked to T cell activation are likely to be downstream of 
direct miR-34c-5p mRNA targets. Of note, the comparison of our dataset with a previously 
published microarray time-course study of the Jurkat transcriptome in response to TCR 
stimulation (Riley et al, 2002) identified an additional group of 11 genes altered by miR-34c-5p 
that were not linked to T cell activation by the GO term annotation (Table EV5). This corresponds 
to a significant degree of overlap between the two datasets, reinforcing the putative role of mir-
34c-5p in this process. 
These results suggest that miR-34c-5p overexpression in Jurkat cells leads to an up-regulation 
of genes critically involved in TCR signaling, thereby providing a possible explanation for the 
observed increased efficiency of HIV-1 production.  
 
miR-34c-5p regulates genes involved in HIV replication 
To further investigate the interactions between miR-34c-5p and HIV-1, we compared the DE 
genes with the HIV-1 Human Interaction Database (Ako-Adjei et al, 2015). We found that 30 of 
the 82 DE genes have been reported to either interact with HIV-1 proteins, regulate replication 
efficiency or be modulated by HIV-1 infection (Fig 7A and Table EV6). This overlap between 
J34c DE genes and known HIV interacting genes was found to be significant using a 
hypergeometric distribution test (Table EV6). Thus, in addition to its interaction with T cell 
activation, miR-34c-5p appears to regulate several critical pathways for viral replication. Manual 
annotation of these genes reveals that most of them are membrane proteins (primarily of the 
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cellular membrane but also ER and Golgi associated), interacting with envelope and other 
structural proteins, or proteins involved in viral encapsidation (Fig 7A). Six of these genes are 
cytoplasmic proteins involved in signal transduction and three are transcriptional regulators (Fig 
7A). Of these 30 genes, 6 are directly annotated in the database as enhancers of viral replication 
whilst two are inhibitors (Table EV6). Strikingly, in spite of the observed positive impact of miR-
34c-5p on HIV-1 replication, most of the reported enhancers were found to be negatively 
regulated by miR overexpression in Jurkat cells (Fig 7A and Table EV6). Additionally, the 
transcriptional co-activator KAT2B (also known as PCAF), which is required for efficient Tat-
dependent transcription from the viral LTR (D'Orso & Frankel, 2009) was also amongst the miR-
34c-5p down-regulated genes (Fig 5A and 5B). This result was confirmed by protein 
quantification, whilst 3’ UTR reporter assays revealed KAT2B/PCAF as a direct target of the miR 
(Fig 7B). Moreover, KAT2B/PCAF mRNA levels increased in J34c cells treated with the 
anatgomir against miR-34c-5p (Fig 7B). To confirm that KAT2B/PCAF is a direct target of miR-
34c, we performed luciferase assays in HEK 293 cells using a reported vector with a 200bp 
region of the 3’UTR that is predicted to contain two miR binding sites, co-transfected with the 
pre-mR-34c-5p pcDNA3 vector (Fig 7C). Results suggest that miR-34c-5p is able to down-
regulate KAT2B/PCAF expression levels by binding to the mRNA 3’UTR. Of note, quantification 
of KAT2B mRNA in naive CD4 T cells during activation and HIV-1 infection revealed a strong 
negative correlation with miR-34c-5p levels, supporting that this interaction also occurs in 
primary cells (Fig EV5).  
The targeting of KAT2B by miR-34c-5p would be predicted to result in reduced viral replication. 
However, our experiments clearly show that the functional outcome of the changes induced by 
the overexpression of this miR in Jurkat T cells is enhanced viral replication (Fig 4). Thus, we 
conclude that the combined impact of miR-34c-5p expression on multiple genes and pathways 
generates a cellular environment favoring HIV production, and we hypothesize that the down-
regulation of miR-34c-5p levels in HIV infected primary cells may be part of a host response to 
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restrict viral replication. 
Overall, our results clearly show that miR-34c-5p is a novel regulator of naive T cell activation 
that can impact on HIV infection by targeting multiple genes linked to TCR signaling and host-
virus interaction pathways.  
 
Discussion 
miRs allow for the fine-tuning of cell responses to the environment and are key mediators of cell 
differentiation pathways (Ivey & Srivastava, 2010). These processes lie at the core of immune 
function, and are particularly important in CD4 T cells, the “orchestrators” of immune responses 
(Pagani et al, 2013).  CD4 T cells represent the main target of HIV, which co-opts the process of 
cell activation and differentiation for several steps of its life cycle, and critically depends on them 
for productive infection (Stevenson et al, 1990). To help identify miRs that potentially link T cell 
activation and HIV replication, we profiled miR expression in purified naive CD4 T cells and then 
asked how it is modulated by both events using high-depth small-RNA-seq. Using this approach, 
we provide here the first comprehensive overview of the miR landscape of highly purified human 
naive CD4 T cells. We show that although HIV is able to efficiently infect this quiescent 
population, it does not significantly impact upon miR expression. TCR-mediated stimulation 
resulted, as expected, in significant alterations of the miR profile, enabling us to identify miR-
34c-5p as a novel player in T cell activation. Furthermore, we found a consistent down regulation 
of miR34c-5p upon HIV-infection of TCR-stimulated naive CD4 T cells, revealing miR-34c-5p as 
a link between these two processes. 
miR-34c-5p is a member of the miR-34 family, which in humans is composed of three miRs 
sharing the same seed sequence: miR-34a, miR-34b and miR-34c (Rokavec et al, 2014).  The 
miR-34 family was originally described as a critical regulator of the DNA damage response, 
being both transcriptionally regulated by p53 and in turn regulating several p53-target genes (He 
et al, 2007). In fact, epigenetic silencing and chromosomal deletions of the miR-34 loci have 
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been reported in several tumors (Toyota et al, 2008; Chim et al, 2011), leading to the proposal 
that they act as tumor suppressor genes. Additionally, miR-34c-5p has been shown to be 
important in brain development and function, as well as stem-cell pluripotency regulation, 
cilliogenesis, and cell movement and migration, processes that are of particular relevance in the 
immune system (reviewed by Rokavec et al, 2014). 
A role for the miR-34 family in TCR-mediated cell activation has not been previously reported. 
This likely reflects the paucity of studies focusing on purified human naive CD4 T cells, many of 
which relied on low-depth qPCR or microarray-based approaches (Pagani et al, 2013). 
Additionally, most NGS studies use so-called “resting” CD4 T cells to investigate T cell 
activation. This may yield reduced sensitivity in revealing miR variations as this population 
includes differentiated T-helper subsets, known to feature specific miR profiles (Kroesen et al, 
2015). Supporting this hypothesis, a qPCR-based miR profiling study of IFNγ-stimulated human 
cells identified miR-34c-5p up-regulation in human cord blood T cells, which are known to be 
mainly composed of naive cells, but not in adult circulating CD4 T cells (Takahashi et al, 2012).  
Maintenance of the naive status and the regulation of the threshold for TCR activation have 
been partially ascribed to miRs, suggesting they act as important regulators of human naive CD4 
T cell homeostasis (reviewed by (Baumjohann & Ansel, 2013)). We found that TCR stimulation 
of purified naive CD4 T cells altered the abundance of approximately half of the detected miRs, 
though only the changes in miR-155-5p and miR-34c-5p levels were robust enough to reach 
statistical significance. Of note, miR-34c-5p was not detected in non-stimulated naive CD4 T 
cells and was the only member of the miR-34 family expressed upon TCR-stimulation. These 
indicate a very specific transcriptional and processing control leading to the synthesis of this miR 
in naive CD4 T cells.  
Our longitudinal study revealed differences in the kinetics of induction of miR-34c-5p and miR-
155. The latter is known to be up-regulated soon after stimulation (Haasch et al, 2002). 
Conversely, the increase in both mature and precursor miR-34c-5p was only clearly detected 
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72h post-TCR stimulation, declining as cell proliferation reached plateau. These results suggest 
that miR-34c-5p is likely involved in late stages of the TCR stimulation program, potentially 
linked with a particular gain of function and/or the differentiation of a cell subset. Interestingly, 
both the FOXO3 transcription factor and the p38 MAPK signalling pathway have been shown to 
specifically regulate transcription of the miR-34b/c cluster (Kress et al, 2011; Cannell et al, 
2010), and are known to play important roles in T cell differentiation (Hedrick et al, 2012; 
Ashwell, 2006).   
The standard approach to address miR function in a human cell type is to perform over-
expression and down-regulation studies involving the transfection of miR mimics or antagonists. 
However, we found that transfection efficiency of ex-vivo purified naive CD4 T cells is very low, 
and that they were subject to a high degree of cell death when this process is performed after 
TCR stimulation. Therefore, we evaluated the impact of miR-34c-5p on T cell function by stably 
transfecting the Jurkat cell line. miR-34c-5p over-expressing cells displayed only minor 
proliferative impairment, contrasting with previous reports that used transient transfection (He et 
al, 2007; Toyota et al, 2008), which is likely related to the clone selection procedure. 
Transcriptome analysis identified a small number of genes whose levels of expression were 
significantly altered in J34c cells. These genes were found to be strongly associated with 
functions previously reported for miR-34c-5p (Rokavec et al, 2014), and additionally to immune 
processes. Furthermore, known interactions of miR-34c-5p targets displayed a very strong 
connection to the TCR signalling pathway. Strikingly, this connection was primarily established 
through up-regulated, rather than down-regulated genes, which are more likely to represent 
direct miR targets. Additionally, a significant overlap was found between miR-34c-5p regulated 
genes and early TCR response genes in Jurkat cells (Riley et al, 2002). Hence, the available 
evidence strongly suggests that miR-34c-5p acts as a regulator of T cell activation, interacting 
with several pathways that contribute to the fine-tuning of T cell responses. 
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Of note, miR-34c-5p levels were consistently reduced upon both HIV-1 and HIV-2 infection of 
TCR-stimulated cells. This down-regulation was particularly notable considering that the miR 
expression profile of TCR-activated naive CD4 T cells was relatively stable 24h post-HIV 
infection, a time-point selected in order to avoid confounding effects resulting from significant 
levels of cell death. Our findings are in agreement with a recent report that identified only 
modest changes in cellular miRs early after infection (Whisnant et al, 2013).  
Additionally, we found that HIV also does not significantly impact miR expression in quiescent 
naive CD4 T cells, despite the evidence of infection and generation of significant levels of 
proviral DNA.  Recent data point to the ability of HIV to infect and establish latency in resting 
CD4 T cells (Chavez et al, 2015; Zerbato et al, 2016). This has important implications for the 
development of complementary therapeutic strategies to control the viral reservoirs that persist 
under antiretroviral therapy. The lack of significant virus production in infected quiescent CD4 T 
cells has been in part ascribed to the presence of host restriction factors, which are down-
regulated upon cell activation. We show that, similar to HIV-1, HIV-2 does not induce alterations 
in the miR profile of naive CD4 T cells. Unlike HIV-1, HIV-2 encodes vpx that promotes the 
degradation of SAMHD1, an important HIV restriction factor in quiescent cells (Baldauf et al, 
2012). Previous studies have shown that quiescent naive CD4 T cells transfected with a plasmid 
encoding vpx support productive HIV-1 infection through the vpx-mediated reduction of 
SAMHD1 (Baldauf et al, 2012).  These first data regarding HIV-2 infection of naive CD4 T cells 
provide evidence that vpx-mediated processes in quiescent cells do not lead to a distinct profile 
of viral parameters as compared to HIV-1, nor in a perturbation of their miR profile. Furthermore, 
results suggest that presence of vpx is not sufficient to overcome the restriction for productive 
HIV-2 infection of naïve cells, in agreement with a previous report using quiescent CD4 T cells, 
irrespective of the naïve/memory phenotype (Chauveau et al 2015). These findings are in 
agreement with the relatively more benign clinical course of HIV-2 as compared to HIV-1, despite 
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both viruses being able to induce immune hyperactivation (Sousa et al, 2002; Grossman et al, 
2002). 
There are many studies addressing the impact of cellular miRs on HIV replication and on the 
establishment of latency (reviewed by (Barichievy et al, 2015)). Specifically, miR-155-5p, miR-
146a-5p, miR-21-5p and the miR-17~92 cluster, which are highly expressed and play a role in 
CD4 T cell activation and differentiation (reviewed by (Kroesen et al, 2015)), have been shown 
to target several pathways of the HIV life cycle (Barichievy et al, 2015). Although our main 
question was whether HIV infection impacts on the miR profile of CD4 T cells and its connection 
to T cell activation, we further explored the direct impact of the miR-34c-5p on viral replication. 
For this purpose, we infected our stably-transfected Jurkat T cell lines and found that miR-34c-
5p expression resulted in increased viral production. This observation was confirmed using an 
antagomiR to specifically knockdown miR-34c-5p, which further revealed opposing effects in 
pre-integration processes and net viral production.   
The complexity of the regulatory interactions between miR-34c-5p and the cellular pathways 
known to be relevant for HIV infection was also highlighted by the transcriptome analysis of miR-
overexpressing cells. Of note, in parallel with gene expression changes that concur with the 
observed increase in viral production, negative modulation of several well-recognized cellular 
genes critical for efficient HIV replication was observed in these cells. In the case of 
PCAF/KAT2B, we show that this is a direct effect of miR binding to the 3’UTR, resulting in 
reduced protein levels in J34c cells, and observe a strong inverse correlation between miR and 
mRNA levels in primary CD4 T cells, both uninfected and HIV infected. Notwithstanding, it 
appears that the combined effect of the miR on multiple pathways relevant for T cell activation 
and HIV life cycle results in a positive balance in favour of viral replication. Interestingly, several 
studies have suggested that miR-34a-5p enhances HIV-1 replication in several cell line models 
via the targeting of different pathways (Kapoor et al, 2015; Zhang et al, 2012; Farberov et al, 
2015). Although our data show that miR-34a-5p is not expressed in primary CD4 T cells, these 
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previous results support the ability of the miR-34 seed sequence to modulate the cell 
environment in a way that promotes viral production. It is therefore tempting to speculate that the 
observed down-regulation of miR-34c-5p upon HIV-1 or HIV-2 infection is part of a host 
response against the virus.  
Overall, we identified miR-34c-5p as a novel miR strongly induced by TCR stimulation of naive 
CD4 T cells, and found that it was consistently down-regulated in response to viral infection. 
Finally, we demonstrate that miR-34c-5p alters the expression of several genes involved in TCR 
signaling and cell activation and that its over-expression has a positive effect on HIV-1 
replication, confirming its role as a novel regulator of naive CD4 T cell activation potentially 
targeted by HIV.  
 
 
 
Materials and Methods  
 
Human samples, cell isolation and TCR-stimulation 
This study was approved by the Ethical Board of the Faculty of Medicine of the University of 
Lisbon, and all subjects provided written consent. Peripheral blood mononuclear cells (PBMC) 
were isolated from buffy coats of healthy individuals by Ficcol-Paque PLUS (GE Healthcare) 
density gradient centrifugation, followed by isolation of naive CD4 T cells by negative selection 
using the EasySep™ Human Naive CD4 T Cell Enrichment kit (Stem Cell Technologies). Purity 
was always >97% (%CD45RA+CD45ROnegCD4+CD3+ cells by flow cytometry). Naive cells 
were cultured in RPMI1640 supplemented with 10% FBS, 2mM L-glutamine, 100U/ml 
penicillin/100μg/ml streptomicin, and 0.05mg/ml Gentamicin (all from Invitrogen). For TCR-
stimulation, 2.5x106 cells/ml were cultured for 72h with plate-bound anti-CD3 mAb (1μg/ml, clone 
OKT3, eBioscience), soluble anti-CD28 mAb (1μ/ml,  clone 28.2, BDPharmingen) and IL-2 
(10IU/ml, Dr. Maurice Gately, Hoffmann–La Roche Inc, NIH AIDS Reagent Program). Cells were 
subsequently switched to medium with IL-2 for prolongued time-course assays.  
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Virus production and HIV infections  
293T cells were transfected with pRod (NIBSC - Centre for AIDS Reagents, Medical Research 
Council UK) or pNL4-3 (NIH AIDS Reagent Program) for 24h using fuGENE HD Transfection 
Reagent (Roche). The amount of virus in cell-free culture supernatants was quantified in terms 
mass of active reverse transcriptase (ng RT) using the Cavidi Lenti RT Activity Kit (Cavidi Tech 
AB), a non-radioactive ELISA-method that measures RT-dependent DNA synthesis in the extract 
normalized to a standard curve of recombinant HIV-1 RT protein. This test that was shown to 
have similar efficacy for both viruses (Nunes-Cabaço et al, 2015; Soares et al, 2011a). Viral 
stocks were concentrated by ultracentrifugation (30min/50,000g/4ºC; Beckmann L8-60M) before 
resuspension in culture medium supplemented with polybrene (3µg/ml; Sigma), and used to 
infect unstimulated and TCR-stimulated primary cells or stably-transfected cell lines, at a dose of 
0.853ng RT/106 cells, during 3h culture under standard conditions (37ºC/5%CO2). Primary cells 
were then extensively washed to remove residual virus, resuspended in medium with  IL-2 
(10IU/ml) and polybrene (3µg/ml), and cultured for additional 24h, after which cells and 
supernatants were collected and immediately stored at -80ºC.  HIV-1NL43 infected cell lines were 
maintained in culture medium with polybrene (3µg/ml) and Geneticin® (G418 Sulfate 1mg/ml; 
Invitrogen), and culture supernatants and cell pellets were harvested at 24h and 48h. Infection 
was assessed by quantifying cell-associated viral DNA and gag mRNA levels using previously 
validated methodologies for use with clinical samples from HIV infected individuals (Soares et al, 
2011b; 2011a; Nunes-Cabaço et al, 2015), HIV-1 tat mRNA was quantified by RT-qPCR as 
described below, and RT activity in supernatants using SYBR green product-enhanced RT (SG-
PERT), as previously described (Nunes-Cabaço et al, 2015), with the adequate controls (see Fig 
EV1). 
 
Flow cytometry 
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Naive CD4 T cell response to TCR stimulation was assessed by flow cytometry through surface 
and intracellular staining performed, as previously described (Tendeiro et al, 2012), using the 
following mAbs: PE-conjugated CD71 (OKT9, eBioscience), PerCP-conjugated Ki67 (B56, BD 
Biosciences), APC-conjugated CD25 (2A5, BD Biosciences). Viral production at the single-cell 
level was assessed by flow cytometry by quantifying intracellular HIV using an anti-Gag Ab 
(KC57, Beckman Coulter), as previously described (Nunes-Cabaço et al, 2015). 
 
Cloning and generation of stably transfected cell lines 
The pre-miR-34c sequence was PCR amplified from HEK293 genomic DNA using primers with 
BamHI and XhoI restriction sites and cloned into the pcDNA3.1 vector (Invitrogen). The PCAF 
3’UTR sequence was amplified from human cDNA and cloned into the PvuI and SpeI sites of the 
pEZX dual reporter vector, downstream of the firefly luciferase sequence. Plasmids were 
sequenced to confirm the absence of mutations. The Jurkat E6-1 cell-line (ATCC TIB-152) was 
used to produce stably transfected T cells over-expressing miR-34c-5p (J34c) by electroporation 
using the Neon Transfection System 100µl Kit in a Microporator MP-100 instrument (Invitrogen). 
Control Jurkat cells (J∅) were generated by paralel transfection of Jurkat cells with the empty 
pcDNA3.1 vector. Prior to transfection, both the pre-miR-34c plasmid and pcDNA3.1 vector were 
linearized with the restriction enzyme PvuI (Fermentas). Transfected cells were cultured for 7d in 
RPMI1600 with 10%FBS and Geneticin® (G418 Sulfate 1mg/ml; Invitrogen). Antibiotic resistant 
cells were frozen to generate the J34c and J∅ parental pools. Single clones were isolated from 
the parental pools using clonaCell-TCS (Stemcell technologies). Primer sequences are provided 
in the Appendix. 
 
RNA, DNA and protein extraction 
Total RNA was isolated using mirVana miRNA Isolation kit for naive CD4 T cells or TRIzol 
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reagent for Jurkat cells (both from Ambion – Thermo Fisher Scientific). RNA quantification was 
performed on ND-1000 spectrophotometer (NanoDrop Technologies) and RNA integrity 
validated using RNA 6000 Nano LabChip kits on a 2100 Bioanalyzer instrument (Agilent 
Technologies). Total RNA samples from multiple individuals were pooled for the generation of 
sequencing libraries (see below) and re-quantified using Qubit (Life technologies). DNA was 
isolated using the QIAamp DNA Mini Kit (Qiagen). For western-blotting, proteins were extracted 
from the organic fractions from the TRIzol procedure.  
 
AntagomiR assays 
miRNA knock-down assays were performed according (Haftmann et al, 2015), using the 
reported  control antagomiR-Scr, and design strategy for a miR-34c-5p specific antagomiR, 
custom synthesized by Dharmacon with the following sequence and modifications:  
5’mG(*)mC(*)mAmAmUmCmAmGmCmUmAmAmCmUmAmCmAmCmUmG(*)mC(*)mC(*)mU(*)
(3’-Chl)3' (where mN - 2′-O-methyl nucleotide; (*) - phosphorothioate modification of the 
backbone, (3’-Chl) – 3’ cholesterol addition) . 
Jurkat cells were 24h cultured (37ºC/5%CO2), in 5mlRPMI1640 with 10%FBS and Geneticin® 
(G418 Sulfate 1mg/ml; Invitrogen). miR-34c-5p knock-down was optimized by varying 
concentrations and incubation time for the antagomiR, and testing for the optimal time-point for 
maximum knock-down and persistence of the effect by semi-quantitative RT-PCR quantification 
as described below. In the optimized protocol, 5x105 cells were washed with cold PBS 
(300g/8min), ressuspended in 250µl serum-free medium (ACCELL, Dharmacon) supplemented 
with 1mM of antagomiR-34c-5p or control antagomiR-Scr, and incubated in a 24-well plate for 4h 
(37ºC/5%CO2), followed by addition of 375µl medium to each well, and further 24h incubation. 
AntagomiR treated cells were used in infection experiments as described above.  
 
RT-PCR 
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miR RT-qPCR assays were performed using TaqMan MicroRNA Reverse Transcription Kit and 
TaqMan microRNA Assays (Applied Biosystems). For semi-quantitative analysis of miR-34c-5p, 
200ng of total RNA was Poly-A tailed using the Poly A Polymerase in a 10µl reaction (New 
England Biolabs). NZY M-MuLV Reverse Transcriptase (NZYTech) was used for cDNA synthesis 
from poly-adenilated total RNA for miR amplification using an oligo-dT adaptor primer (see 
Appendix), or from cellular total RNA using standard oligo-dT (for human mRNAs) or random 
hexamer priming (for tat-rev mRNA). The NZYTaq DNA polymerase (NZYTech) was used for 
semi-quantitive analysis of miR-34c-5p or pre-miR-34c levels. qPCR quantification of cDNA 
samples was performed using the SsoFast EvaGreen Supermix (BioRad) in a BioRad CFX96 
Real-Time PCR Detection system. Relative expression was calculated by the ΔCt method 
against house-keeping genes HPRT1 or GAPDH for mRNA and RNU48 or hsa-miR-21 for 
miRNAs. Detection sensitivity limit of miR-34c-5p by qPCR was calculated using a synthetic 
RNA oligonucleotide identical to miR-34c-5p (IBA GmBH), reverse transcribed with the TaqMan 
miR-34c-5p reverse transcription kit (Applied Biosystems), and using ten 5-fold serial dilutions of 
the resulting cDNA, ranging from 2x10-5 µM to 1x10-11 µM of input RNA equivalents. Resulting Ct 
data was plotted in GraphPad Prism and a fit to an exponential growth curve was generated and 
used to interpolate unknown values. Primer sequences are presented in the Appendix.  
 
Reporter assays and Western-blotting 
To analyze the interaction of miR-34c-5p with KAT2B 3’UTR, HEK293 cells were transfected with 
a 1:1 mix of miR-34c-5p pcDNA construct and either pZEX-KAT2B 3’UTR or pZEX empty vector, 
in triplicate using Fugene 6 (Promega). After 24h, firefly and renilla luciferase levels were 
determined using Promega Dual-glo luciferase assay on Promega Glomax plate reader. The 
mean values of the luciferase to renilla firefly ratio of 4 independent assays were compared 
using two tailed t-test. Western-blotting was performed with the Anti-KAT2B/PCAF ChIP Grade 
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(ab12188) and the Anti-Histone H3 Ab - Nuclear Loading Control and ChIP Grade (Ab1791) from 
Abcam. 
 
Small RNA-Seq design and sequencing  
15-30bp were purified by gel fractionation and used to generate small RNA-seq libraries using 
the Illumina Small RNA-seq protocol. The small-RNA-seq libraries used in this study were 
generated in three distinct experiments (Table EV7). Dataset 1 is composed by one library per 
condition (unstimulated and stimulated), each generated by pooling equal amounts of total RNA 
from 9 individual samples, and sequenced on a whole flow cell of a Genome Analyser II 
sequencer using the Chrysalis 36 cycles v4.0 sequencing kit (Illumina). Sequencing libraries for 
datasets 2 and 3 were generated from the pooling of equal amounts of total RNA from naive 
uninfected, HIV-1 infected and HIV-2 infected cells isolated from 3 individuals. Dataset 2 is 
composed by two sets of replicate libraries from unstimulated cells (corresponding to a total of 6 
donnors), while Dataset 3 is composed by three replicate libraries from stimulated cells 
(corresponding to a total of 9 donnor samples), which were sequenced on 20% of a HiSeq2000 
sequencer lane using the TruSeq SBS v5 sequencing kit (Illumina). The same 3’ sequencing 
adaptor (ATCTCGTATGCCGTCTTCTGCTTGT) was used in all experiments and was removed 
from raw data before analysis. Raw sequencing data from Dataset 1 was pre-processed using 
the SCS.2.6 and CASAVA.1.6 pipeline (Illumina). Raw reads from Datasets 2 and 3 were pre-
processed using the HiSeq Control Soft. V 1.3.8, RTA 1.10.36, CASAVA 1.7.0 and OLB-1.9.0 
(Illumina). The ArrayExpress accession code for the small-RNA-seq datasets is E-MTAB-4214. 
RNA-seq datasets used for miR expression profiling are presented in Table EV7 
 
Small RNA-Seq data analysis  
Quality control and filtering was performed using in house developed PERL scripts 
(ComputerCodeEV1) with removal of reads with homopolymers, uncalled bases or san average 
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Phred QS<20. Quality approved reads were searched against known miRNAs (miRbase v16) 
(Griffiths-Jones et al, 2006), using in house developed PERL scripts to obtain expression 
sequence counts for mature miR species (ComputerCodeEV2). Remaining sequence tags were 
aligned to human reference genome (NCBI build 37) using Bowtie 0.12.7 (Langmead, 2010), 
allowing one mismatch. Sequences were classified regarding locus of origin by positional 
comparison with coding regions (NCBI build 37) and other non-coding RNAs (RFam database) 
(Griffiths-Jones et al, 2005), using the intersectBed function of BEDtools (Quinlan & Hall, 2010). 
Reads without annotation were analyzed for putative novel miRNAs using MapMi (Guerra-
Assunção & Enright, 2010), self-containment of RNA structures (Lee & Kim, 2008)  and 
miRDeep2 (Friedländer et al, 2012). Library normalization was performed using the mean 
normalization method available in Deseq package of Bioconductor (Anders & Huber, 2010). 
Differential expression analysis was performed with DESeq, which applies a Fisher's exact test 
after performing a transformation using the Negative Binomial (NB) model to account for 
overdispersion. Clustering analysis was performed using the heatmap function from ggplot 
package (default parameters) in R (R Core Team, 2016). For prediction of target genes of 
differentially expressed miRNAs, PITA (Kertesz et al, 2007), MiRanda (Griffiths-Jones et al, 
2006) and TargetScan 5.2 (Lewis et al, 2003) were used. For downstream analysis, only targets 
predicted by at least two algorithms were selected. 
 
Microarray profiling and network analysis 
The transcriptome of J34c and JØ clones was profiled using the Affymetrix Human Gene ST 
array v2.0 at the EMBL core facility. Datasets are publicly available in ArrayExpress under the 
accession number E-MTAB-4190. Microarray data analysis was performed using RMA (Irizarry 
et al, 2003) and Bioconductor packages Aroma (Bengtsson & Hössjer, 2006) and Limma (Smyth, 
2004). DE genes were evaluated using a linear model approach implemented in Limma. p-
values were adjusted for multiple testing, across all genes and all comparisons, Benjamini and 
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Hochberg corrections to control the expected false discovery rate at less than 5%. Gene set 
enrichment analysis was performed using GOStats (Falcon & Gentleman, 2007). GeneMania 
plugin (Montojo et al, 2010) of Cytoscape (Shannon et al, 2003) was used to generate an 
interaction nework for DE genes and predict underlying network functions based on the 
statistical analysis of GO term frequencies.  The network was manually annotated to highlight 
genes linked to T cell signalling, HIV interactome, Jurkat activation and up- or down-regulation 
status. 
 
Statistical analysis 
The statistical tests used are mentioned in the corresponding figure legends and were 
implemented using GraphPad Prism software or, alternatively, in R Statistical environment (R 
Core Team, 2016) when specifically mentioned.  
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Figures Legends 
 
 
Figure 1 - miR expression profile of naive CD4 T cells and impact of HIV infection.  
A Relative abundance of miR species in human naive CD4 T cells. Cell purity was >97%.  
B, C Average miR expression levels in unstimulated naive CD4 T cells non-infected vs HIV-1NL4-3  
(B) or HIV-2ROD (C) infected after 24h (n=2, three pooled samples per library). Mean normalized 
read counts across libraries are shown. Library normalization was performed using the mean 
normalization method available in the Deseq package of Bioconductor (Anders & Huber, 2010). 
Lines indicate changes of +/- 1 log2 fold between samples.  
 
Figure 2 - miR-34c-5p is up-regulated in naive CD4 T cells in response to TCR-mediated 
stimulation.  
A Average miR expression levels in naive CD4 T cells (purity >97%) before and after 72h TCR-
stimulation. Lines indicate changes of +/- 1 log2 fold between samples (n=2, paired pools of 
three and nine individual samples per library). Library normalization performed using the mean 
normalization method available in Deseq package of Bioconductor (Anders & Huber, 2010). 
miRs with significant changes are highlighted (black) and with insets presenting mean read 
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counts in unstimulated samples (mean), log2 fold change values in stimulated samples (log FC) 
and corresponding adjusted p value (p; Fisher test implemented in Deseq). The two most highly 
expressed miRs (mir-21-5p and miR-146b-5p) are also indicated.  
B Relative miR-34c-5p and miR-155-5p expression levels (2deltaCt normalized to RNU48) in 
unstimulated and stimulated naive CD4 T cells of individual samples pooled to generate the 
sequencing libraries. mean ± SEM and p-value for differences in miR-155-5p expression (paired 
two tailed t-test) are shown. Comparison could not be performed for miR-34c-5p as it is 
undetermined in unstimulated samples. 
C Time course quantification of miR-34c-5p expression (top panel, 2deltaCt values), cell 
proliferation (middle panel) and cell activation (bottom panel) markers by flow cytometry, in three 
different donors.  
 
Figure 3 - Changes in miR expression in response to HIV infection of TCR-stimulated 
naive CD4 T cells.  
A, B Comparison of the mean miR expression level by in TCR-stimulated naive CD4 T cell small 
RNA-seq libraries from uninfected and HIV-1NL4-3 (A) or HIV-2ROD (B) infected samples (24h). 
Only miRNAs with a minimum of 10 normalized read counts. Library normalization was 
performed using the mean normalization method available in Deseq package of Bioconductor 
(Anders & Huber, 2010). Lines indicate changes of +/- 1 log2 fold between samples (n=3, paired 
pools of three individual samples per library). miR-34c-5p is highlighted in black.  
C Quantification of miR-34c-5p expression levels of the individual samples pooled to generate 
the sequencing libraries by qPCR (mean±SEM 2deltaCt values and p value from a paired two 
tailed t test; n=5).  
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Figure 4 - Impact of miR-34c-5p expression on HIV infection and replication.  
A Cell-associated viral DNA levels (left), Tat mRNA levels (center), and RT activity levels (right) 
in cell culture supernatants in infected J34c cells vs. infected JØ cells at 24 and 48 hours post-
infection. * p≤0.05 (paired two tailed t test).  
B Representative flow cytometry plot of intracellular HIV-1 Gag protein staining (KC57) versus 
side scatter (SSC) in JØ and J34c cells, mock infected or infected with HIV-1NL4-3, after 48 hours 
of culture and corresponding fold change (J34c/JØ) plot in four biological replicate assays. 
Differences to control were found to be significant with a paired two tailed t test (p≤0.05). 
C Fold change levels for miR-34c-5p, cell-associated viral DNA level, Tat mRNA, and RT activity 
levels in J34c cells treated with miR-34c-5p antagomiR versus control antagomiR, 48 hours 
post-infection. Differences to control were found to be significant with a paired two tailed t test 
(p≤0.05). 
All plots show fold change levels observed in a total of three biological replicate experiments 
performed (four for panel B). Lines depict the corresponding mean and SEM values.  
 
Figure 5 - Impact of miR-34c-5p overexpression on Jurkat T cells.  
A Hierarchical clustering of the 82 differentially expressed (DE) genes identified in Jurkat cell 
lines overexpressing miR-34c-5p (J34c-2 and J34c-5) vs control (JØ-1, 2 and 3 clones). Color 
scale represents mean centered log2 fold expression level across samples. Pie charts represent 
the relative proportion of predicted miR-34c-5p binding sites by the Miranda or PITA algorithms 
(or both) in down-regulated (top) and up-regulated (bottom) gene sets.  
B qRT-PCR validation of selected genes. Plot represents the average percentage of target gene 
mRNA (normalized to GAPDH) in J34c vs  JØ cells (all differences were found to be significant 
with a paired two tailed t test, P<0.05; n=5).  
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Figure 6 – Functional enrichment and network analysis of the miR-34c-5p-dependent 
transcritome in Jurkat T cells.  
A Distribution of enriched GO terms (Biological Processes) in J34c DE genes grouped into nine 
functional categories. Bar chart represents the number of expected and observed hits for GO 
terms associated with ‘Immune response’.  
B Gene interaction network for J34c DE genes (filled nodes) and additional highly connected 
genes (transparent nodes). Node size reflects the number of network connections. 
 
Figure 7 – miR-34c-5p targets in the HIV interactome. 
A Interaction network between genes regulated by miR-34c-5p and HIV-1 proteins. Figure 
depicts the subset of DE genes identified in J34c cells that have reported interactions with HIV-1 
proteins in the HIV interactome database (Ako-Adjei et al, 2015), as well as their subcellular 
localization and function (see also Table EV6).  
B Western-blot of PCAF/KAT2B and histone H3 in JØ or J34c (top), confirming decrease in 
protein levels. Bottom: antagomiR to miR-34c-5p results in increased KAT2B mRNA levels 
compared to control-treated cells. Plot presents relative expression values for mRNA in 3 
biological replicates; bars represent mean and SEM. Differences were found to be significant 
with p<0.05 (paired two tailed t test). 
C Predicted target sites for miR-34c-5p in the PCAF/KAT2B mRNA(black bars) and miR-target 
hybridization for the two strongest sites (top); Luciferase assay with the pEZX renilla/firefly-
PCAF/KAT2B 3’UTR reporter in HEK293 cells co-transfected with either the miR-34c-5p 
overexpression vector or pcDNA3 empty control (bottom). Differences were found to be 
significant with p<0.05 (paired two tailed t test, n=5). 
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Expanded View Figure Legend 
 
Figure EV1 – HIV infection parameters in sequencing library samples.  
A Cell-associated proviral DNA (top) and gag mRNA (center) levels upon HIV-1 and HIV-2 
infection of the naïve CD4 T cells used to generate the sequencing libraries analyzed in Fig 1. 
Each dot represents one individual, with color identifying the individual samples pooled together 
for subsequent NGS analysis. Whiskers represent the median and interquartile range. Bottom: 
illustrative semi-quantitative PCR for HIV-1 tat-rev spliced mRNA from naive CD4 T cells non-
infected (NI) or HIV-1 infected (HIV) along with G6PC housekeeping gene.   
B Hierarchical clustering of the normalized expression counts of all miRNA species in 
sequencing libraries from unstimulated CD4 T cells, either non-infected (NI) or infected with HIV 
(HIV1 or HIV2). Index a and b identify paired libraries generated by pooling samples from the 
same set of three donors. 
C Levels of cell-associated proviral DNA (top) and gag mRNA (center) upon HIV-1 and HIV-2  
infection of the TCR-stimulated naïve CD4 T cell samples used to generate the sequencing 
libraries analyzed in Fig 3. Each dot represents one individual, with individual samples pooled 
together for subsequent NGS analysis identified by the same color. Whiskers represent median 
and interquartile-range. Bottom: illustrative semi-quantitative PCR for HIV-1 tat-rev spliced 
mRNA from stimulated naive CD4 T cells non-infected (NI) or HIV-1 infected (HIV), and G6PD 
housekeeping gene.  
 
Figure EV2 - Changes in naïve CD4 T cell miR expression profile in response to TCR 
stimulation.   
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A Relative abundance of miR species after 72h TCR-stimulation.  
B miR-34c-5p detection sensitivity assay. Plot shows Ct values for serial 1:5 dilutions of a miR 
mimic standard. Number of molecules in each data point is indicated, as well as information 
regarding the exponential fit and estimate of the number of molecules that correspond to the 
maximum Ct cycles of standard qPCR assays. 
C Compiled data for relative miR-34s-5p expression (normalized to RNU48) in the 10 individual 
samples analyzed in Fig 2B, Fig 22 and Fig EV2 E. To allow for fold change calculation and 
statistical comparison, undetermined Ct values for non-stimulated samples were set to 43 (red 
asterisk). Differences between conditions are significant with p<0.05 (paired two tailed  test)  
D Comparative analysis of miR-34c-5p and miR-155 levels. Illustrative fold change in miR  
abundance for one of the individual samples in the time-course experiment in Fig 2C. For 
representation purposes of the RT-qPCR data, miR-34c-5p CtT0=40.  
E Time-course of pri-miR-34c expression. Representative pri-miR-34c and G6PD housekeeping 
gene expression levels assessed by semi-quantitative RT-PCR in 72h TCR-stimulated naive 
CD4 T cells (top, one out of 3); and levels of mature miR-34c-5p quantified in parallel by RT-
qPCR (2-dCT)  (bottom) with the statistics for variation along time in the 3 samples tested shown 
in the table below (ANOVA test).  
 
Figure EV3 - miR-34c-5p expression levels in Jurkat cell lines and clones and set-up of 
antagomiR assays.  
A Ct values for miR-34c-5p and miR-21 in Jurkat cell lines stably transfected with the pcDNA3 
empty vector (JØ) or pcDNA3 containing the pri-miR-34c-5p sequence (J34c).  JØ and J34c 
pools used for infection experiments presented in Fig 4, and in clonal populations isolated from 
each of these pools (JØ-1 to 3 and J34c-2, 4 and 5) used in the microarray profiling study 
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presented in Fig 5 are shown. miR-34c-5p was undetectable in all JØ samples, in agreement 
with parental Jurkat cells. Table presents estimate of number of miR-34c molecules in each 
sample based on the standard sensitivity curve presented in Fig. EV2B, and corresponding 
estimated fold increase. 
B miR-34c-5p and miR-21 levels in J34c cells treated with antagomiRs after 24h and 72h (top) 
or 96h (bottom) by RT-PCR. miR levels in untreated J34c and JØ are also shown (bottom). 
qPCR quantification of miR levels in cells treated with antagomiRs compared to untreated J34c 
cells in shown for one assay (left). 
 
Figure EV4 – Quality control of the transcriptome profiling dataset of J34c and JØ cell 
lines with Affimetrix Human Gene 2.0 arrays.  
A NUSE plot  
B RLE plot  
C Unsupervised clustering analysis of the transcriptome  
D Principal component analysis 
JØ-1, -2 and -3: control clones; J34c-2, -4 and -5: miR-34c-5p overexpressing clones (see Fig 
EV3A.  
 
 
Figure EV5 - miR-34c-5p and PCAF/KAT2B expression in naive CD4 T cells.  
A Quantification of PCAF/KAT2B and miR-34c-5p expression levels in naive CD4 T cells isolated 
from two healthy donors by qRT-PCR in response to TCR-stimulation.   
B Same as A. in HIV-1 infected vs. non-infected stimulated cells after 72h TCR-stimulation.  
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Each symbol represents one individual. Relative expression corresponds to 2-dCT values, 
normalized to RNU48. 
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Table 1. Differentially expressed miRs in response to HIV-1 or HIV-2 
infection of TCR-stimulated naive CD4 T cells. 
microRNA 
Mean 
Expression  
In Stimulated 
Naive CD4  
T cells  
HIV-1 infection HIV-2 infection 
Log2 FC adj p Log2 FC adj p 
hsa-miR-34c-5p 1679.07 -1.83 7.00E-01 -2.44 2.49E-05 
hsa-miR-143-3p 3622.56 -2.79 2.35E-07 no change na 
hsa-miR-126-3p 3811.84 -2.14 6.89E-04 no change na 
hsa-miR-126-5p  12086.65 -1.68 2.68E-02 no change na 
hsa-miR-379-5p 977.22 -2.04 2.26E-02 no change na 
hsa-miR-1268a 8906.17 2.35 2.25E-02 no change na 
Only miRs with mean expression above 500 reads are reported; Log2 FC – log2 
fold change; no change - absolute log2 fold change smaller than 1. adj p – adjusted 
p value for detected fold change. Only miRs with adj p <0.05 are reported. na – not 
applicable. 
 
 
 
 





